RGn600

· REGEnLIFE SAS

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RGn600, covering 2025-04-06 to 2025-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease [NA]